Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Woman Killed in Pedestrian Crash on State Route 94 Near Jamul Casino


Victim Hit by Minivan in Fatal Jamul Accident

Pedestrian Fatality

Jamul, CA (January 2, 2020) – A woman was killed in a pedestrian crash in Jamul. The fatal accident occurred on the evening of January 2 on State Route 94.

A woman was walking along State Route 94, near the Jamul Casino on Campo Road, when she was hit by a minivan. Paramedics arrived to provide medical assistance, but the woman died at the accident scene. The driver of the minivan remained at the scene.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Jamul

#91935


November 13, 2019

Several Injured in Crash on Highway 299

2 Vehicles Involved in Burney Accident...


May 19, 2020

1 Killed in Crash on Bee Canyon Truck Trail

Vehicle Crashes in Remote Area of Hemet...


May 5, 2020

Pedestrian Killed in Crash at South Delaware Street and 9th Avenue

Man Dies in Fatal San Mateo Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.